: Following the close of the transaction on May 5, 2021 , GWPH shares were delisted from the NASDAQ. How to Invest in GW Pharmaceuticals' Legacy
Since GW Pharmaceuticals is now part of , investors interested in its cannabinoid platform—including the blockbuster epilepsy drug Epidiolex —must buy shares of the parent company.
: Integration of GW has diversified Jazz's neuroscience portfolio, with Epidiolex contributing significantly to its revenue. Current Market Data for Jazz Pharmaceuticals (JAZZ) buy gwph stock
As of late April 2026, Jazz Pharmaceuticals continues to trade on the NASDAQ. You can track its performance on major financial platforms: View real-time quotes on . Check analyst ratings and fair value on Investing.com .
: GWPH shareholders received $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). : Following the close of the transaction on
: The deal was valued at approximately $7.2 billion .
: This is the current entity that owns all former GWPH assets and continues to develop its pipeline. Current Market Data for Jazz Pharmaceuticals (JAZZ) As
Monitor institutional holdings and earnings reports on .
